BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29523669)

  • 1. Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.
    Mohile SG; Magnuson A; Pandya C; Velarde C; Duberstein P; Hurria A; Loh KP; Wells M; Plumb S; Gilmore N; Flannery M; Wittink M; Epstein R; Heckler CE; Janelsins M; Mustian K; Hopkins JO; Liu J; Peri S; Dale W
    J Natl Compr Canc Netw; 2018 Mar; 16(3):301-309. PubMed ID: 29523669
    [No Abstract]   [Full Text] [Related]  

  • 2. The Effect of a Geriatric Oncology Clinic on Treatment Decisions in Mexican Older Adults With Cancer.
    Verduzco-Aguirre HC; Navarrete-Reyes AP; Chavarri-Guerra Y; Ávila-Funes JA; Soto-Perez-de-Celis E
    J Am Geriatr Soc; 2019 May; 67(5):992-997. PubMed ID: 30644088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.
    Loh KP; Mohile SG; Lund JL; Epstein R; Lei L; Culakova E; McHugh C; Wells M; Gilmore N; Mohamed MR; Kamen C; Aarne V; Conlin A; Bearden J; Onitilo A; Wittink M; Dale W; Hurria A; Duberstein P
    Oncologist; 2019 Jun; 24(6):e292-e302. PubMed ID: 31015317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.
    Moth EB; Kiely BE; Naganathan V; Martin A; Blinman P
    Support Care Cancer; 2018 Feb; 26(2):451-460. PubMed ID: 28776149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.
    Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
    J Geriatr Oncol; 2019 Mar; 10(2):202-209. PubMed ID: 30224184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does older age influence oncologists' cancer management?
    Foster JA; Salinas GD; Mansell D; Williamson JC; Casebeer LL
    Oncologist; 2010; 15(6):584-92. PubMed ID: 20495217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study.
    Puts MT; Sattar S; McWatters K; Lee K; Kulik M; MacDonald ME; Jang R; Amir E; Krzyzanowska MK; Leighl N; Fitch M; Joshua AM; Warde P; Tourangeau AE; Alibhai SM
    Support Care Cancer; 2017 Mar; 25(3):879-886. PubMed ID: 27830393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilisation of geriatric assessment in oncology - a survey of Australian medical oncologists.
    To THM; Soo WK; Lane H; Khattak A; Steer C; Devitt B; Dhillon HM; Booms A; Phillips J
    J Geriatr Oncol; 2019 Mar; 10(2):216-221. PubMed ID: 30041979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologists' End of Life Treatment Decisions.
    Bluhm M; Connell CM; Janz N; Bickel K; DeVries R; Silveira M
    J Appl Gerontol; 2017 Apr; 36(4):416-440. PubMed ID: 26198272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Being present: oncologists' role in promoting advanced cancer patients' illness understanding.
    Cohen SM; Maciejewski RC; Shah MA; Trevino KM; Shen MJ; Maciejewski PK; Prigerson HG
    Cancer Med; 2018 Apr; 7(4):1511-1518. PubMed ID: 29479843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer.
    Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
    J Geriatr Oncol; 2019 Mar; 10(2):210-215. PubMed ID: 30503312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
    Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
    J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy.
    Pini TM; Hawley ST; Li Y; Katz SJ; Griggs JJ
    Breast Cancer Res Treat; 2012 Jul; 134(2):867-74. PubMed ID: 22718307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
    Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
    Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Future Radiation Oncologists Equipped With the Knowledge to Manage Elderly Patients With Cancer?
    Morris L; Thiruthaneeswaran N; Lehman M; Hasselburg G; Turner S
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):743-747. PubMed ID: 28258899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab.
    Keating NL; O'Malley AJ; Onnela JP; Gray SW; Landon BE
    JAMA Netw Open; 2020 Jan; 3(1):e1918586. PubMed ID: 31899533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
    Katz SJ; Hawley ST; Bondarenko I; Jagsi R; Ward KC; Hofer TP; Kurian AW
    Breast Cancer Res Treat; 2017 Oct; 165(3):751-756. PubMed ID: 28689364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and clinical decision making in oncology patients.
    Yellen SB; Cella DF; Leslie WT
    J Natl Cancer Inst; 1994 Dec; 86(23):1766-70. PubMed ID: 7966414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative chemotherapy or watchful waiting? A vignettes study among oncologists.
    Koedoot CG; De Haes JC; Heisterkamp SH; Bakker PJ; De Graeff A; De Haan RJ
    J Clin Oncol; 2002 Sep; 20(17):3658-64. PubMed ID: 12202667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.